We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$69.9B
AUM Growth
–
Cap. Flow
+$69.7B
Cap. Flow
% of AUM
99.63%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
251
New
251
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.9B |
| 2 |
Amgen
AMGN
|
+$3.88B |
| 3 |
Eli Lilly
LLY
|
+$2.66B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.6B |
| 5 |
Microsoft
MSFT
|
+$2.07B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.42% |
| 2 | Technology | 26.27% |
| 3 | Industrials | 12.15% |
| 4 | Financials | 7.16% |
| 5 | Consumer Discretionary | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$29.5B
| $3.93B | 5.62% |
+18,246,809
| New | +$3.9B |
|
|
2
Amgen
AMGN
$197B
| $3.68B | 5.27% |
+37,348,991
| New | +$3.88B |
|
|
3
Alphabet (Google) Class C
GOOG
$4.29T
| $2.69B | 3.85% |
+122,812,292
| New | +$2.6B |
|
|
4
Eli Lilly
LLY
$1.02T
| $2.4B | 3.44% |
+48,900,865
| New | +$2.66B |
|
|
5
Microsoft
MSFT
$2.99T
| $2.18B | 3.12% |
+63,165,491
| New | +$2.07B |
|
6
Texas Instruments
TXN
$259B
| $1.99B | 2.85% |
+57,212,465
| New | +$2.05B |
|
7
Novartis
NVS
$285B
| $1.91B | 2.74% |
+30,213,008
| New | +$1.97B |
|
8
FedEx
FDX
$73.1B
| $1.9B | 2.71% |
+19,242,579
| New | +$1.87B |
|
9
Adobe
ADBE
$93.3B
| $1.83B | 2.61% |
+40,090,232
| New | +$1.78B |
|
10
Medtronic
MDT
$107B
| $1.65B | 2.37% |
+32,130,321
| New | +$1.59B |
|
|
SCHW
11
Charles Schwab
SCHW
$178B
| $1.51B | 2.16% |
+71,035,703
| New | +$1.31B |
|
|
MON
12
DELISTED
Monsanto Co
MON
| $1.21B | 1.73% |
+12,225,167
| New | +$1.28B |
|
13
Johnson & Johnson
JNJ
$599B
| $1.2B | 1.72% |
+13,996,087
| New | +$1.19B |
|
|
MRSH
14
Marsh
MRSH
$87.7B
| $1.16B | 1.66% |
+29,135,363
| New | +$1.14B |
|
15
Southwest Airlines
LUV
$23.6B
| $1.04B | 1.49% |
+80,811,875
| New | +$1.1B |
|
16
Qualcomm
QCOM
$180B
| $1.04B | 1.49% |
+17,010,025
| New | +$1.09B |
|
17
Intuit
INTU
$80.4B
| $1.03B | 1.47% |
+16,861,778
| New | +$1.02B |
|
18
Bath & Body Works
BBWI
$4.13B
| $989M | 1.41% |
+24,845,074
| New | +$1B |
|
|
LIFE
19
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $987M | 1.41% |
+13,339,442
| New | +$968M |
|
20
Honeywell
HON
$71.7B
| $978M | 1.4% |
+13,711,511
| New | +$946M |
|
|
DTV
21
DELISTED
DIRECTV COM STK (DE)
DTV
| $922M | 1.32% |
+14,966,390
| New | +$896M |
|
22
Visa
V
$686B
| $873M | 1.25% |
+19,102,060
| New | +$836M |
|
23
Oracle
ORCL
$350B
| $746M | 1.07% |
+24,270,386
| New | +$805M |
|
24
TJX Companies
TJX
$172B
| $637M | 0.91% |
+25,452,592
| New | +$628M |
|
25
Gen Digital
GEN
$16.1B
| $632M | 0.9% |
+28,140,669
| New | +$662M |
|
Similar funds
Primecap Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Primecap Management, which disclosed 251 positions worth $69.9B. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Biogen: 18,246,809 shares worth $3.93B.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Technology and Industrials.
- Primecap Management's largest Q2 2013 buy was Biogen: 18,246,809 shares worth $3.93B.
- Primecap Management's ten largest holdings make up 36% of its $69.9B portfolio in Q2 2013.
- Primecap Management disclosed 251 positions in Q2 2013, its first 13F filing on record.
Based on Primecap Management's 13F filing for Q2 2013, filed 14 Aug 2013.